TY - JOUR
T1 - Natural products chlorotonils exert a complex antibacterial mechanism and address multiple targets
AU - Deschner, Felix
AU - Mostert, Dietrich
AU - Daniel, Jan Martin
AU - Voltz, Alexander
AU - Schneider, Dana Carina
AU - Khangholi, Navid
AU - Bartel, Jürgen
AU - Pessanha de Carvalho, Laís
AU - Brauer, Madita
AU - Gorelik, Tatiana E.
AU - Kleeberg, Christian
AU - Risch, Timo
AU - Haeckl, F. P.Jake
AU - Herraiz Benítez, Laura
AU - Andreas, Anastasia
AU - Kany, Andreas Martin
AU - Jézéquel, Gwenaëlle
AU - Hofer, Walter
AU - Müsken, Mathias
AU - Held, Jana
AU - Bischoff, Markus
AU - Seemann, Ralf
AU - Brötz-Oesterhelt, Heike
AU - Schneider, Tanja
AU - Sieber, Stephan
AU - Müller, Rolf
AU - Herrmann, Jennifer
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/4/17
Y1 - 2025/4/17
N2 - Antimicrobial resistance is a threat to human health rendering current first-line antibiotics ineffective. New agents overcoming resistance mechanisms are urgently needed to guarantee successful treatment of human disease in the future. Chlorotonils, a natural product class with yet unknown mode of action, were shown to have broad-spectrum activity against multi-resistant Gram-positive bacteria and the malaria parasite Plasmodium falciparum, with promising activity and safety in murine infection models. Here, we report that chlorotonils can target the cell membrane, cell wall, and protein biosynthesis. They can be characterized by a rapid onset of action via interference with ion homeostasis leading to membrane depolarization, however, without inducing severe barrier failure or cellular lysis. Further characterization confirmed binding of chlorotonils to bacterial membrane lipids eventually leading to uncontrolled potassium transport. Additionally, we identified functional inhibition of the peptidoglycan biosynthesis protein YbjG and methionine aminopeptidase MetAP as secondary targets of chlorotonils.
AB - Antimicrobial resistance is a threat to human health rendering current first-line antibiotics ineffective. New agents overcoming resistance mechanisms are urgently needed to guarantee successful treatment of human disease in the future. Chlorotonils, a natural product class with yet unknown mode of action, were shown to have broad-spectrum activity against multi-resistant Gram-positive bacteria and the malaria parasite Plasmodium falciparum, with promising activity and safety in murine infection models. Here, we report that chlorotonils can target the cell membrane, cell wall, and protein biosynthesis. They can be characterized by a rapid onset of action via interference with ion homeostasis leading to membrane depolarization, however, without inducing severe barrier failure or cellular lysis. Further characterization confirmed binding of chlorotonils to bacterial membrane lipids eventually leading to uncontrolled potassium transport. Additionally, we identified functional inhibition of the peptidoglycan biosynthesis protein YbjG and methionine aminopeptidase MetAP as secondary targets of chlorotonils.
KW - Antibiotics
KW - antimicrobial resistance
KW - chlorotonil
KW - lipids
KW - membrane
KW - MetAP
KW - mode of action
KW - natural product
KW - proteomics
KW - YbjG
UR - http://www.scopus.com/inward/record.url?scp=105002400952&partnerID=8YFLogxK
U2 - 10.1016/j.chembiol.2025.03.005
DO - 10.1016/j.chembiol.2025.03.005
M3 - Article
AN - SCOPUS:105002400952
SN - 2451-9456
VL - 32
SP - 586-602.e15
JO - Cell Chemical Biology
JF - Cell Chemical Biology
IS - 4
ER -